Riskpilot← Back to searchSign inGet full accessSolkliniken AB
ABActiveOrg 5569793200Rubinvägen 38General medical practice activities · NACE 8621Est. 20144 employees
Revenue 2025
SEK 2,3M
+6% vs 2024
EBITDA margin
-14.5%
-199% vs 2024
Equity ratio
39.2%
Financial strength
Net profit 2025
SEK -64K
-125% vs 2024
| Revenue | SEK 2,3M | +6% |
| EBITDA | SEK -335K | -199% |
| Net profit | SEK -64K | -125% |
| Total assets | SEK 1,1M | -38% |
| Equity | SEK 442K | -33% |
| Employees | 4 | — |
Legal name
Solkliniken AB
Org number
5569793200
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 augusti 2014
Share capital
SEK 50 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva läkarverksamhet samt förvaltning av värdepapper, handel med juveler, fordon, fastigheter och annan därmed förenlig versamhet.
Address
Rubinvägen 38
Email
solkliniken@hotmail.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 238 | 2 218 | 2 174 | 2 180 | 2 315 |
| Staff expenses | — | −1 622 | −1 664 | −1 440 | −2 284 |
| EBITDA | 409 | 294 | 159 | 339 | −335 |
| Depreciation & amort. | −134 | −134 | −133 | −134 | −134 |
| EBIT | 275 | 160 | 26 | 206 | −468 |
| Net financials | −23 | −14 | −7 | 0 | −5 |
| Profit before tax | 81 | 223 | 139 | 343 | −64 |
| Tax | −23 | −51 | −38 | −89 | — |
| Net profit | 58 | 172 | 100 | 253 | −64 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 073 | 2 474 | 2 223 | 1 810 | 1 127 |
| Equity | 987 | 502 | 602 | 655 | 442 |
| Long-term debt | 365 | 187 | 0 | — | — |
| Short-term debt | 977 | 1 119 | 1 074 | 744 | 686 |
| Total debt | 1 342 | 1 306 | 1 074 | 744 | 686 |
EBITDA margin
-14.5%
This company
15.8%
Market median
-192% vs market
20212025
Equity ratio
39.2%
This company
38.2%
Market median
+3% vs market
20212025
Return on equity
-14.4%
This company
18.4%
Market median
-178% vs market
20212025
Net profit margin
-2.7%
This company
8.1%
Market median
-133% vs market
20212025
Asset turnover
2.05×
This company
1.12×
Market median
+83% vs market
20212025
Debt / equity
1.55×
This company
0.62×
Market median
-150% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AH | Audit | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Solkliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Henrik Tobias Molin | Audit | 0 companies |
| Abduljabbar Abdulilah Abduljabbar | Board of Directors | 0 companies |
| Hamza Abduljabbar Abdulilah | Deputy Board Member | 0 companies |